MBX Biosciences Inc. Common Stock
MBX | NASDAQ
$61.73
+$0.79 (+1.30%)
Sep 22, 2026, 2:22 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -60.61M | -23.52M | -22.06M | -21.62M | -19.41M | -23.88M | -15.59M | -18.14M | -15.86M | -12.34M | -8.84M | -10.16M | -7.61M |
Depreciation & Amortization | 143K | -579K | 865K | 50K | -979K | 77K | 58K | 75K | 63K | 48K | 41K | 40K | 39K |
Stock-Based Compensation | 11.55M | 5.48M | 2.66M | 2.25M | 1.94M | 1.84M | 1.49M | 1.19M | 919K | 1.62M | 1.02M | 596K | 225K |
Other Working Capital | 6.19M | -5.67M | 2.43M | 531K | -1.09M | 2.16M | -1.27M | 542K | 1.44M | -40K | -2.55M | 1.53M | -529K |
Other Non-Cash Items | -846K | 98K | -1.33M | -702K | 101K | -1.31M | -1.37M | -560K | -414K | -478K | -506K | 9K | 86K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 6.94M | -1.69M | 1.57M | -1.51M | 918K | 600K | -627K | 2.77M | 2.02M | 434K | -2.86M | 1.79M | 102K |
Operating Cash Flow | -42.83M | -20.21M | -18.3M | -21.54M | -17.43M | -22.68M | -16.04M | -14.66M | -13.27M | -10.71M | -11.15M | -7.73M | -7.38M |
Capital Expenditures | -1.34M | -437K | -793K | -399K | -707K | -30K | -92K | -57K | -452K | -273K | -55K | -22K | -31K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -208.05M | -154.16M | -205.43M | -46.4M | -47.43M | -58.89M | -87.5M | -127.73M | -15.69M | -8.55M | -33.9M | -20.58M | n/a |
Sales Maturities Of Investments | 141.5M | 57.5M | 76.25M | 63.85M | 73.12M | 57.15M | 20.25M | 27M | 8.25M | 24.25M | 5M | 2M | 20M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 1M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -67.89M | -97.1M | -129.97M | 17.06M | 25.99M | 3.23M | -67.35M | -100.79M | -7.89M | 15.43M | -28.96M | -18.61M | 19.97M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -151K | n/a | n/a | n/a | n/a | n/a | -132K | n/a | n/a | n/a | 19K | n/a | n/a |
Financial Cash Flow | 89.76M | 87.44M | 438K | 187.82M | 1.33M | 4K | -132K | 235.81M | -1.76M | 183K | 19K | 68.5M | 634K |
Net Cash Flow | -20.96M | -29.87M | -147.84M | 183.34M | 9.88M | -19.45M | -83.51M | 120.36M | -22.92M | 35.43M | -40.08M | 42.17M | 13.22M |
Free Cash Flow | -44.17M | -20.65M | -19.09M | -21.94M | -18.14M | -22.71M | -16.13M | -14.72M | -13.72M | -10.98M | -11.2M | -7.75M | -7.41M |
Adj. Free Cash Flow | -55.72M | -26.13M | -21.75M | -24.18M | -20.08M | -24.55M | -17.62M | -15.91M | -14.64M | -12.61M | -12.22M | -8.34M | -7.64M |
Maintenance CapEx | -143K | -437K | -793K | -50K | -707K | -30K | -58K | -57K | -63K | -48K | -41K | -22K | -31K |
Growth CapEx | -1.2M | n/a | n/a | -349K | n/a | n/a | -34K | n/a | -389K | -225K | -14K | n/a | n/a |
Owner Earnings | -42.97M | -20.65M | -19.09M | -21.59M | -18.14M | -22.71M | -16.1M | -14.72M | -13.33M | -10.76M | -11.19M | -7.75M | -7.41M |
Add to Watchlist
Select watchlists to add or remove MBX